Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Britannia shares fall 5% despite decent Q4 show. Do Morgan Stanley, Nomura see any upside?Britannia Industries shares dropped significantly even as the company reported a profit increase. The FMCG major's fourth-quarter earnings ...
08 May, 2026, 10.13 AM IST
AI battle heats up, OPEC fractures: Arnab Das on the two biggest market stories right nowGlobal markets face two major shifts: intense AI competition sees Anthropic challenging OpenAI's dominance, raising questions about AI's mo...
29 Apr, 2026, 10.21 AM IST
Steve Englander on US dollar, oil and the surprising market resilienceGlobal markets are navigating geopolitical tensions with surprising resilience, particularly in the US. Despite initial fears, financial as...
24 Apr, 2026, 11.55 AM IST
Global Market Today: Asian stocks gain, dollar wobbles as Trump extends Iran ceasefireU.S. stock futures rose and the dollar wavered after President Trump announced an indefinite extension of the Iran ceasefire, buoying marke...
22 Apr, 2026, 06.34 AM IST
GIFT City’s IPO push faces teething issuesGIFT City's first IPO withdrawal, XED Executive Development's Rs 110 crore offering, highlights challenges for its stock listing ambitions....
10 Apr, 2026, 10.17 AM IST
IT mojo returns pre-Q4 results; Flipkart's AI sprintIT stocks have gained momentum ahead of Q4 results. This and more in today's ETtech Top 5.
08 Apr, 2026, 07.57 PM IST
Strides Pharma shares fall over 3% on plans to spin off CDMO, gelatin businessesAs per Trendlyne data, the average target price of Strides Pharma is Rs 530, which shows a downside of 2% from the current market prices. T...
26 Sep, 2023, 12.17 PM IST
Strides Pharma announces business rejig. Shares end 7% up, hit 52 week highThe announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday's...
25 Sep, 2023, 05.07 PM IST
Smallcap pharma stock jumps over 11% as arm receives tentative USFDA approval for HIV drug DolutegravirThe company has 260 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of whic...
15 Sep, 2023, 12.45 PM IST
Buy Strides Pharma Science, target price Rs 355: EdelweissStrides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 2914.80 Crore) operating in Pha...
09 Mar, 2022, 09.07 AM IST
Buy Strides Pharma, target price Rs 495: Motilal OswalThe brokerage expects earnings to triple over FY20–22, led by new product commercialization and higher volume share gains in existing produ...
22 May, 2020, 01.02 PM IST
Strides plunges 8% as USFDA finds significant violation at facilityThe US drug regulator said it also found a blue binder containing CGMP records.
17 Jul, 2019, 04.02 PM IST
Buy Strides Pharma Science, target Rs 495: Manas JaiswalBuy Strides Pharma Science Ltd. at a price target of Rs 495.0 and a stoploss at Rs 465 from entry point.
10 Jan, 2019, 09.15 AM IST
Sell Strides Pharma Science, target Rs 405: Manas JaiswalSell Strides Pharma Science at a price target of Rs 405 and a stop loss at Rs 451 from the entry point.
01 Oct, 2018, 09.07 AM IST
Strides Shasun plunges 7% on earnings woesThe fresh weakness came on top of 23 per cent drop on Friday after the lacklustre earnings.
21 May, 2018, 11.07 AM IST
Sell Strides Shasun, target Rs 502: Dr CK NarayanSell Strides Shasun Ltd. at a price target of Rs 502 and a stop loss at Rs 522 from entry point.
15 May, 2018, 09.02 AM IST